Wipro GE Healthcare has introduced Versana Premier R3, an advanced AI-powered ultrasound system designed to enhance clinical efficiency, streamline workflows, and improve diagnostic accuracy.
Manufactured at the company’s PLI factory in Bengaluru, the launch aligns with the Indian government’s ‘Make in India’ initiative.
The company believes that with India’s 1.4 billion population and a rising burden of non-communicable diseases (NCDs), there is a growing need for healthcare technologies that facilitate precise diagnosis and reduce administrative workload.
The Versana Premier R3, an extension of the Versana ultrasound range, integrates artificial intelligence to enhance workflow automation and improve clinical accuracy.
The system is equipped with AI-driven productivity tools, dynamic tissue imaging optimisation, volume calculation assistance, and a self-learning onboarding tool to support skill development among clinicians.
Chaitanya Sarawate, Managing Director, Wipro GE Healthcare South Asia, said, “At Wipro GE Healthcare we continue to make advancements in AI, investing in foundation models that can help enhance precision care, ease clinical workflows and enable better patient outcomes. AI is central to building a future where healthcare is personalised, preventive, and affordable.”
“The launch of our Versana Premier R3, is yet another testament to our commitment towards the delivery of Made in India MedTech, for India and the world.”
Emphasising the need for AI-driven healthcare solutions, Anup Kumar, business head, Ultrasound, Wipro GE Healthcare, stated that powered by AI, Versana Premier R3 delivers exceptional image clarity and versatile organ scanning, enhancing diagnostic precision, and empowering clinicians to make timely and well-informed decisions.
According to a recent PwC report, 57% of healthcare providers in India have adopted AI, surpassing global adoption rates. The Versana Premier R3’s
‘VisionBoost architecture’ and 8-million-channel digital processing contribute to superior image clarity, while compatibility with 23 different probes enables dynamic organ scanning.
Wipro GE Healthcare has been a strong proponent of the ‘Make in India’ initiative for decades. Products manufactured at its PLI factory include the Revolution Aspire CT system and the Optima IGS320 AI-enabled Cath Lab.
Earlier this year, the company announced an investment of over INR 8,000 crores in manufacturing output and local R&D over the next five years.
Further, AIIMS partnered with Wipro GE Healthcare in December 2024 to advance AI-driven healthcare solutions. With AIIMS offering real-world clinical insights and Wipro GE Healthcare committing a $1 million investment, the collaboration aims to redefine key medical fields like cardiology, oncology, and neurology through intelligent systems and workflow innovations.
